[Low-dosage ASA should not be given as primary prevention. The risk is greater than the benefit--also in high risk of cardiovascular disease]

MeSH terms

• Age Factors
• Aspirin / administration & dosage*
• Aspirin / adverse effects
• Cardiovascular Diseases / prevention & control*
• Fibrinolytic Agents / administration & dosage*
• Fibrinolytic Agents / adverse effects
• Humans
• Primary Prevention
• Risk Factors
• Secondary Prevention
• Sex Factors